狠狠色丁香久久综合婷婷亚洲成人福利在线-欧美日韩在线观看免费-国产99久久久久久免费看-国产欧美在线一区二区三区-欧美精品一区二区三区免费观看-国内精品99亚洲免费高清

            上海源葉生物科技有限公司

            主營(yíng)產(chǎn)品: S30260異硫氰酸胍,30259鹽酸胍,嗜熱菌蛋白酶

            15

            聯(lián)系電話

            15921386130

            您現(xiàn)在的位置: 上海源葉生物科技有限公司>>小分子化合物>>小分子抑制劑>> S81188

            公司信息

            聯(lián)人:
            何小姐
            話:
            86-021-61559134
            機(jī):
            15921386130
            真:
            86-021-55068248
            址:
            上海市松江區(qū)長(zhǎng)塔路465號(hào)6幢
            編:
            200433
            網(wǎng)址:
            www.shyuanye.com
            鋪:
            http://apwanrong.com/st191837/
            給他留言
            S81188
            S81188
            參考價(jià) 面議
            具體成交價(jià)以合同協(xié)議為準(zhǔn)
            • 型號(hào)
            • 品牌
            • 廠商性質(zhì) 生產(chǎn)商
            • 所在地

            更新時(shí)間:2024-07-03 18:59:56瀏覽次數(shù):136

            聯(lián)系我們時(shí)請(qǐng)說(shuō)明是化工儀器網(wǎng)上看到的信息,謝謝!

            【簡(jiǎn)單介紹】
            提示:詳情請(qǐng)下載說(shuō)明書(shū)
            • 提示:詳情請(qǐng)下載說(shuō)明書(shū)。
            • 產(chǎn)品描述: Pantoprazole (BY10232) is an orally active and potent proton pump inhibitor (PPI). Pantoprazole, a substituted benzimidazole, is a potent H+/K+-ATPase inhibitor with an IC50 of 6.8 μM. Pantoprazole improves pH stability and has anti-secretory, anti-ulcer activities. Pantoprazole significantly increased tumor growth delay combined with Doxorubicin (HY-15142)
            • 靶點(diǎn): proton pump
            • 體內(nèi)研究: Pantoprazole (BY1023; 200 mg/kg; IP; once a week for 3 weeks) significantly increases tumor growth delay of MCF-7 xenografts combined with Doxorubicin. Pantoprazole (0.3-3 mg/kg, p.o.) dose-dependently decreases both basal acid secretion in pylorus-ligated rats and the stimulated acid secretion induced by mepirizole in acute fistula rats.
            • 參考文獻(xiàn):
              1. Krupa J Patel, et al. Use of the proton pump inhibitor pantoprazole to modify the distribution and activity of doxorubicin: a potential strategy to improve the therapy of solid tumors. Clin Cancer Res. 2013 Dec 15;19(24):6766-76. 2. Huarui Zhang, et al. Advances in the discovery of exosome inhibitors in cancer. J Enzyme Inhib Med Chem. 2020 Dec;35(1):1322-1330. 3. W Beil, et al. Pantoprazole: a novel H+/K(+)-ATPase inhibitor with an improved pH stability. Eur J Pharmacol. 1992 Aug 6;218(2-3):265-71. 4. K Takeuchi, et al. Effects of pantoprazole, a novel H+/K+-ATPase inhibitor, on duodenal ulcerogenic and healing responses in rats: a comparative study with omeprazole and lansoprazole. J Gastroenterol Hepatol. 1999 Mar;14(3):251-7.
            • 保存條件: 2-8℃
            • 配置溶液濃度參考:
              1mg 5mg 10mg
              1 mM 2.608 ml 13.042 ml 26.084 ml
              5 mM 0.522 ml 2.608 ml 5.217 ml
              10 mM 0.261 ml 1.304 ml 2.608 ml
              50 mM 0.052 ml 0.261 ml 0.522 ml
            • 注意:部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的性,僅供客戶參考交流研究之用。
            該公司的其它相關(guān)產(chǎn)品查看所有產(chǎn)品 >>


            產(chǎn)品對(duì)比 產(chǎn)品對(duì)比 二維碼

            掃一掃訪問(wèn)手機(jī)商鋪

            對(duì)比框

            在線留言